Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Antineoplastic Agents, Alkylating/*adverse effects"'
Publikováno v:
Acta Cirúrgica Brasileira v.33 n.6 2018
Acta Cirúrgica Brasileira
Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)
instacron:SBDPC
Acta Cirurgica Brasileira, Volume: 33, Issue: 6, Pages: 499-507, Published: JUN 2018
Acta Cirurgica Brasileira, Vol 33, Iss 6, Pp 499-507 (2018)
Acta Cirúrgica Brasileira
Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)
instacron:SBDPC
Acta Cirurgica Brasileira, Volume: 33, Issue: 6, Pages: 499-507, Published: JUN 2018
Acta Cirurgica Brasileira, Vol 33, Iss 6, Pp 499-507 (2018)
Purpose: To evaluate the impact of systemic cyclophosphamide treatment on the rat uterus and investigate the potential therapeutic effects of natural antioxidant preparations curcumin and capsaicin against cyclophosphamide side effects. Methods: A 40
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ff63d0d0fabc4ece44f39649cbda028
https://pubmed.ncbi.nlm.nih.gov/30020311
https://pubmed.ncbi.nlm.nih.gov/30020311
Autor:
Jay-Jiguang Zhu, Manmeet Ahluwalia, Sun Ha Paek, Steven Brem, Francesco Di Meco, David M. Steinberg, Zvi Ram, Steven A. Toms, Chae-Yong Kim, Garth Nicholas, David Tran, Andreas F. Hottinger, Andrew A. Kanner, Ahmed Idbaih, Giuseppe Stragliotto, Gitit Lavy-Shahaf, Michael Weller, Eilon D. Kirson, Frank S. Lieberman, Uri Weinberg, Monika E. Hegi, Yoram Palti, Sophie Taillibert, Roger Stupp, H Hirte, William L. Read, Benoit Lhermitte, Jordi Burna, Karen Fink
Publikováno v:
JAMA, vol. 318, no. 23, pp. 2306-2316
Tumor-treating fields (TTFields) is an antimitotic treatment modality that interferes with glioblastoma cell division and organelle assembly by delivering low-intensity alternating electric fields to the tumor. To investigate whether TTFields improve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a47c8577143871dbe41d3b7c006ef05
https://serval.unil.ch/notice/serval:BIB_868908B10151
https://serval.unil.ch/notice/serval:BIB_868908B10151
Publikováno v:
QJM. 103:449-459
Hypophosphatemia (serum phosphorus concentration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beb1c0f9c17e9b06e52e046f98ac7fda
https://doi.org/10.1093/qjmed/hcq039
https://doi.org/10.1093/qjmed/hcq039
Autor:
Leyvraz, S., Pampallona, S., Martinelli, G., Ploner, F., Perey, L., Aversa, S., Peters, S., Brunsvig, P., Montes, A., Lange, A., Yilmaz, U., Rosti, G., Marrow, Transplantation
Publikováno v:
Journal of the National Cancer Institute, vol. 100, no. 8, pp. 533-541
BACKGROUND: The dose intensity of chemotherapy can be increased to the highest possible level by early administration of multiple and sequential high-dose cycles supported by transfusion with peripheral blood progenitor cells (PBPCs). A randomized tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b94d9825381050dae08a1ce9fb3198bf
https://doi.org/10.1093/jnci/djn088
https://doi.org/10.1093/jnci/djn088
Autor:
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, Van Den Weyngaert D, Kaendler S, Krauseneck P, Vinolas N, Villa S, Wurm RE, Maillot MHB, Spagnolli F, Kantor G, Malhaire JP, Renard L, De Witte O, Scandolaro L, Vecht CJ, Maingon P, Lutterbach J, Kobierska A, Bolla M, Souchon R, Mitine C, Tzuk-Shina T, Kuten A, Haferkamp G, de Greve J, Priou F, Menten J, Rutten I, Clavere P, Malmstrom A, Jancar B, Newlands E, Pigott K, Twijnstra A, Chinot O, Reni M, Boiardi A, Fabbro M, Campone M, Bozzino J, Frenay M, Gijtenbeek J, Delattre JY, De Paula U, Hanzen C, Pavanato G, Schraub S, Pfeffer R, Soffietti R, Kortmann RD, Taphoorn M, Torrecilla JL, Grisold W, Huget P, Forsyth P, Fulton D, Kirby S, Wong R, Fenton D, Cairncross G, Whitlock P, Burdette-Radoux S, Gertler S, Saunders S, Laing K, Siddiqui J, Martin LA, Gulavita S, Perry J, Mason W, Thiessen B, Pai H, Alam ZY, Eisenstat D, Mingrone W, Hofer S, Pesce G, Dietrich PY, Thum P, Baumert B, Ryan G
Publikováno v:
New England Journal of Medicine, vol. 352, no. 10, pp. 987-96
New England Journal of Medicine, 352(10), 987-996. Massachussetts Medical Society
New England Journal of Medicine, 352(10), 987-996. Massachussetts Medical Society
BACKGROUND: Glioblastoma, the most common primary brain tumor in adults, is usually rapidly fatal. The current standard of care for newly diagnosed glioblastoma is surgical resection to the extent feasible, followed by adjuvant radiotherapy. In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf112f90a929a68afabcd377cbf792ea
https://doi.org/10.1056/NEJMoa043330
https://doi.org/10.1056/NEJMoa043330
Autor:
Kijima, Toshiki, Masuda, Hitoshi, Suzuki, Masahito, Okada, Yohei, Yano, Masataka, Hyochi, Nobuhiko, Fujii, Yasuhisa, Kawakami, Satoru, Hayashi, Tetsuo, Kobayashi, Tsuyoshi, Kihara, Kazunori
Publikováno v:
泌尿器科紀要. 49(8):483-486
症例1(36歳女), 症例2(63歳男)はWegener肉芽腫症に対し, 11年間にそれぞれ計104g, 100gのシクロホスファミド(CPM)の投与を受けた.症例3(50歳女)は再発性乳癌に対し, 計57gのCPM投与を受けた.3例とも
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::fa034f98571dbc938bc44738e1b45d3f
http://hdl.handle.net/2433/115021
http://hdl.handle.net/2433/115021
Publikováno v:
泌尿器科紀要. 48(5):301-305
59歳, 男.Malignant lymphomaに対してCyclophosphamideが投与され, 肉眼的血尿を主訴に受診した.CT, IVP, RPにて左腎盂腫瘍を認め, 尿細胞診はクラスVで根治的左腎尿管全摘除術が施行された.病理組織
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::dfe100373788a81309d919db54e794cb
http://hdl.handle.net/2433/114750
http://hdl.handle.net/2433/114750
Autor:
Ana Catarina Pinto, Philippe Aftimos, Evandro de Azambuja, Carmen Criscitiello, Felipe Ades, Dimitrios Zardavas
Publikováno v:
Breast, 23 (4
Several breast cancer therapies can lead to cardiovascular toxicity: drugs such anthracyclines can cause permanent damage, anti-HER2 agents may cause transitory and reversible cardiac dysfunction and others, such as those used in endocrine therapy, p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cea713bd646ecaad19779531718e5c0
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/183636
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/183636
Publikováno v:
Journal of the National Cancer Institute, vol. 89, no. 2, pp. 173-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee37e38833363edb006a1498935c926
https://serval.unil.ch/notice/serval:BIB_2F4421B36FC6
https://serval.unil.ch/notice/serval:BIB_2F4421B36FC6
Autor:
Kosmidis, P., Mylonakis, N., Fountzilas, G., Pavlidis, N., Samantas, E., Karabelis, A., Kattis, K., Skarlos, D.
BACKGROUND: It was recently reported that when ifosfamide was added to cisplatin and vinblastine the response rate was increased but not the survival in patients with non-small-cell lung cancer (NSCLC). The purpose of this study was to investigate th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10561::dfec54cd1271404a35d05fb8829af0e2
http://olympias.lib.uoi.gr/jspui/handle/123456789/24261
http://olympias.lib.uoi.gr/jspui/handle/123456789/24261